Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors

Pathology International

Volumn 62, Issue 9, 2012, Pages 583-591

  Lee, Hyoun Wook ^a   Lee, Eun Hee ^a   Ha, Seung Yeon ^b   Lee, Chang Hun ^c   Chang, Hee Kyung ^d   Chang, Sunhee ^e   Kwon, Kun Young ^f   Hwang, Il Seon ^f   Roh, Mee Sook ^g   Seo, Jeong Wook ^h  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gachon University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Kosin University College of Medicine   (South Korea)

^e Inje University College of Medicine   (South Korea)

^f Keimyung University   (South Korea)

^g Dong A University College of Medicine   (South Korea)

^h Dong A University   (South Korea)

Author keywords

Let 7a; Lung; MicroRNA; MiR 155; MiR 21; Neuroendocrine tumor

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 155; MICRORNA 21; MICRORNA LET 7A; PARAFFIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOID; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL NUCLEAR; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865543992     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02845.x     Document Type: Article

References (29)

1. Travis WD. Lung tumours with neuroendocrine differentiation. Eur J Cancer 2009; 45 (Suppl 1): 251-66.
2. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization International Histological Classification of Tumours. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC press, 2004.
3. den Bakker MA, Willemsen S, Grunberg K etal. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 2010; 56: 356-63.
4. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol 1998; 29: 272-9.
5. Xi Y, Nakajima G, Gavin E etal. Systemic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed, paraffin-embedded samples. RNA 2007; 13: 1668-74.
6. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
7. Caldas C, Brenton JD. Sizing up miRNAs as cancer genes. Nat Med 2005; 11: 712-4.
8. Lagos-Quintana M, Rauhurt R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-8.
9. Bandres E, Agirre X, Ramire N, Zarate R, Garcia-Foncillas J. MicroRNAs as cancer players: Potential clinical and biological effects. DNA Cell Biol 2007; 26: 273-82.
10. Sassen S, Miska EA, Caldas C. MicroRNA: Implications for cancer. Virchows Arch 2008; 452: 1-10.
11. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
12. Yanaihara N, Caplen N, Bowman E etal. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cells 2006; 9: 189-98.
13. Lee JH, Voortmam J, Dingemans AM etal. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS ONE 2011; 6: e21300.
14. Yu SL, Chen HY, Chang GC etal. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cells 2008; 13: 48-57.
15. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008; 54: 1696-704.
16. Volinia S, Calin GA, Liu CG etal. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.
17. Takamizawa J, Konishi H, Yanagisawa K etal. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-6.
18. Lee CH, Chang HK, Lee HW, Shin DH, Roh MS. The interobserver variability for diagnosing pulmonary carcinoid tumor. Korean J Pathol 2010; 44: 267-71.
19. Ha SY, Han J, Kim WS, Suh BS, Roh MS. Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis. Korean J Pathol 2012; 46: 42-7.
20. Beasley MB, Thunnissen FB, Brambila E etal. Pulmonary atypical carcinoid: Predictors of survival in 106 cases. Hum Pathol 2000; 31: 1255-65.
21. Travis WD, Rush W, Flieder DB etal. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22: 934-44.
22. Bagheri R, Mashhadi MR, Haghi SZ, Sadrizadh A, Rezaeetalab F. Tracheobronchopulmonary carcinoid tumors: Analysis of 40 patients. Ann Thorac Cardiovasc Surg 2011; 17: 7-12.
23. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33.
24. Pezzolesi MG, Platzer P, Waite KA, Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in cowden syndrome. Am J Hum Genet 2008; 82: 1141-9.
25. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin I (TPM1). J Biol Chem 2007; 282: 14328-36.
26. Nagao Y, Hisaoka M, Matsuyama A etal. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol 2012; 25: 112-21.
27. Kong W, Yang H, He L etal. McroRNA-155 is regulated by the transforming growth beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008; 28: 6773-84.
28. Rahman MM, Qian ZR, Wang EL etal. Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation. Br J Cancer 2009; 100: 501-10.
29. Johnson SM, Grosshans H, Shingara J etal. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-47.